Efficacy of novel agents in r/r T pro-lymphocytic leukaemia
17 Jun 2018
Efficacy of novel agents in r/r T pro-lymphocytic leukaemia
Development of a risk stratifying prognostic index for ALL
Onset and treatment of infantile leukaemia
Novel CD22 CAR-T therapy for paediatric leukaemia
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia
EHA Topics in focus : Immunotherapy
Novel ADC for relapsed/refractory lymphoma
iNNOVATE trial of added ibrutinib for Waldenströms Macroglobulinemia
Updated results from a phase I trial of CAR-T cell therapy for r/rMM
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma
Updates from Myeloma XI trial
Ribosomal lesions promote oncogenic mutagenesis